Context Therapeutics CNTX Insider Ownership

NASDAQ CNTX
$0.36 -0.01 (-1.59%)
As of: Sep 10, 2026 · 1:18 PM EDT

Insider Holdings by Owner

1.12Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
1.35%
0% pp QoQ
Shares Held by Insiders
1.28Mn
filed for Sep 2026
0.00% QoQ
Shares Outstanding
95.19Mn
95,185,187 shares
Direct Holdings
361.67K
Indirect: 920.19K
Net Shares Traded (QoQ)
0
no net change in Sep 2026
Insiders Holding Shares
5
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest
Average ownership
Peak ownership

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter
Net over range
Buying quarters

Insider Ownership Summary

Quarter ending 30 Sep, 2026

As of September 09, 2026, the three largest insider holders of CNTX are Martin A. Lehr (Chief Executive Officer, 920.19K shares), Martin A. Lehr (Chief Executive Officer, 920.19K shares), Martin A. Lehr (Chief Executive Officer, 159.70K shares).

Form 4 Holdings

Insiders Holding CNTX

Insiders 5
Shares held 1.12Mn
Of outstanding 1.18%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Martin A. Lehr Chief Executive Officer 0 920,190 920,190 82.0% 10 Jun, 2025
2 Evan G. Dick Svp Of Rd 82,960 0 82,960 7.4% 17 Dec, 2021
3 Jennifer Lynn Minai-Azary Chief Financial Officer 80,010 0 80,010 7.1% 10 Jun, 2025
4 Alex C. Levit Chief Legal Officer, Corp. Sec 29,000 0 29,000 2.6% 10 Jun, 2025
5 Tarek Sahmoud Chief Medical Officer 10,000 0 10,000 0.9% 17 Aug, 2022

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

246 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
24 Jun, 2026 Linda West Director Acquired A 45,000 $0.00 $0 45,000 Direct
24 Jun, 2026 Andy Pasternak Director Acquired A 45,000 $0.00 $0 45,000 Direct
24 Jun, 2026 Jennifer Evans Stacey Director Acquired A 45,000 $0.00 $0 45,000 Direct
24 Jun, 2026 Philip W. Kantoff Director Acquired A 45,000 $0.00 $0 45,000 Direct
24 Jun, 2026 Karen L. Smith Director Acquired A 45,000 $0.00 $0 45,000 Direct
19 Feb, 2026 Karen Deborah Chagin Chief Medical Officer Acquired A 290,000 $0.00 $0 290,000 Direct
19 Feb, 2026 Martin A. Lehr Chief Executive Officer Acquired A 815,000 $0.00 $0 815,000 Direct
19 Feb, 2026 Alex C. Levit Chief Legal Officer, Corp. Sec Acquired A 270,000 $0.00 $0 270,000 Direct
19 Feb, 2026 Alex C. Levit Chief Legal Officer, Corp. Sec Acquired A 270,000 $0.00 $0 270,000 Direct
19 Feb, 2026 Alex C. Levit Chief Legal Officer, Corp. Sec Acquired A 270,000 $0.00 $0 270,000 Direct
19 Feb, 2026 Martin A. Lehr Chief Executive Officer Acquired A 815,000 $0.00 $0 815,000 Direct
19 Feb, 2026 Jennifer Lynn Minai-Azary Chief Financial Officer Acquired A 275,000 $0.00 $0 275,000 Direct
19 Feb, 2026 Alex C. Levit Chief Legal Officer, Corp. Sec Acquired A 270,000 $0.00 $0 270,000 Direct
19 Feb, 2026 Martin A. Lehr Chief Executive Officer Acquired A 815,000 $0.00 $0 815,000 Direct
19 Feb, 2026 Martin A. Lehr Chief Executive Officer Acquired A 815,000 $0.00 $0 815,000 Direct
19 Feb, 2026 Jennifer Lynn Minai-Azary Chief Financial Officer Acquired A 275,000 $0.00 $0 275,000 Direct
19 Feb, 2026 Jennifer Lynn Minai-Azary Chief Financial Officer Acquired A 275,000 $0.00 $0 275,000 Direct
19 Feb, 2026 Jennifer Lynn Minai-Azary Chief Financial Officer Acquired A 275,000 $0.00 $0 275,000 Direct
12 Jun, 2025 Karen L. Smith Director Acquired A 123,500 $0.00 $0 123,500 Direct
12 Jun, 2025 Jennifer Evans Stacey Director Acquired A 123,500 $0.00 $0 123,500 Direct